Literature DB >> 9396718

Effect of aging on the chaperone-like function of human alpha-crystallin assessed by three methods.

B K Derham1, J J Harding.   

Abstract

alpha-Crystallin can function as a molecular chaperone by preventing unwanted interactions. This paper presents the effects of aging and cataract on the chaperone-like properties of alpha-crystallin from soluble fractions from the cortex and nucleus of human lenses by using three assays: enzyme inactivation and two turbidity experiments. The three methods complemented each other. There was no decrease with age of chaperone-like function of cortical alpha-low and alpha-high crystallin. Nuclear alpha-low crystallin showed a decrease, whereas alpha-high crystallin showed no age-related change but its protective effect was diminished. Results from the nucleus of 40-year-old cataractous lenses seemed similar to those for clear lenses of equivalent age, whereas 80-year-old cataractous lenses showed decreased chaperone-like behaviour.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396718      PMCID: PMC1218984          DOI: 10.1042/bj3280763

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  The influence of some post-translational modifications on the chaperone-like activity of alpha-crystallin.

Authors:  M A van Boekel; S E Hoogakker; J J Harding; W W de Jong
Journal:  Ophthalmic Res       Date:  1996       Impact factor: 2.892

2.  Prevention of the inactivation of glutathione reductase by fructation using human alpha-crystallin.

Authors:  R Blakytny; J J Harding
Journal:  Biochem Soc Trans       Date:  1995-11       Impact factor: 5.407

3.  Aspartic acid racemisation in the human lens during ageing and in cataract formation.

Authors:  P M Masters; J L Bada; J S Zigler
Journal:  Nature       Date:  1977-07-07       Impact factor: 49.962

4.  Circular dichroism and optical rotatory dispersion of the aggregates of purified polypeptides of alpha-crystallin.

Authors:  L K Li; A Spector
Journal:  Exp Eye Res       Date:  1974-07       Impact factor: 3.467

5.  Population character and variety in subunit structure of high-molecular-weight proteins from the bovine eye lens.

Authors:  F S van Kleef; H J Hoenders
Journal:  Eur J Biochem       Date:  1973-12-17

6.  The nature and origin of the urea-insoluble protein of human lens.

Authors:  J J Harding
Journal:  Exp Eye Res       Date:  1972-01       Impact factor: 3.467

7.  Effect of the oxidation of sulfhydryl groups on lens proteins.

Authors:  M Testa; C Fiore; N Bocci; S Calabrò
Journal:  Exp Eye Res       Date:  1968-04       Impact factor: 3.467

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Changes in human lens proteins during nuclear cataract formation.

Authors:  R J Truscott; R C Augusteyn
Journal:  Exp Eye Res       Date:  1977-02       Impact factor: 3.467

10.  An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.

Authors:  S Vasan; X Zhang; X Zhang; A Kapurniotu; J Bernhagen; S Teichberg; J Basgen; D Wagle; D Shih; I Terlecky; R Bucala; A Cerami; J Egan; P Ulrich
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

View more
  12 in total

1.  Chaperone-like activity of alpha-crystallin is enhanced by high-pressure treatment.

Authors:  Csaba Böde; Ferenc G Tölgyesi; László Smeller; Karel Heremans; Sergiy V Avilov; Judit Fidy
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Tight binding of proteins to membranes from older human cells.

Authors:  Roger J W Truscott; Susana Comte-Walters; Zsolt Ablonczy; John H Schwacke; Yoke Berry; Anastasia Korlimbinis; Michael G Friedrich; Kevin L Schey
Journal:  Age (Dordr)       Date:  2010-12-23

Review 3.  Regulation of αA- and αB-crystallins via phosphorylation in cellular homeostasis.

Authors:  Erin Thornell; Andrew Aquilina
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

4.  Effects of modifications of alpha-crystallin on its chaperone and other properties.

Authors:  Barry K Derham; John J Harding
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

5.  Functionalized resorcinarenes effectively disrupt the aggregation of αA66-80 crystallin peptide related to cataracts.

Authors:  Kwaku Twum; Avik Bhattacharjee; Erving T Laryea; Josephine Esposto; George Omolloh; Shaelyn Mortensen; Maya Jaradi; Naomi L Stock; Nicholas Schileru; Bianca Elias; Elan Pszenica; Theresa M McCormick; Sanela Martic; Ngong Kodiah Beyeh
Journal:  RSC Med Chem       Date:  2021-11-01

6.  The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity.

Authors:  N Pasupuleti; S Matsuyama; O Voss; A I Doseff; K Song; D Danielpour; R H Nagaraj
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

7.  Hydroimidazolone modification of human alphaA-crystallin: Effect on the chaperone function and protein refolding ability.

Authors:  Mahesha H Gangadhariah; Benlian Wang; Mikhail Linetsky; Christian Henning; Robert Spanneberg; Marcus A Glomb; Ram H Nagaraj
Journal:  Biochim Biophys Acta       Date:  2010-01-18

8.  Identification of crystallin modifications in the human lens cortex and nucleus using laser capture microdissection and CyDye labeling.

Authors:  C O Asomugha; R Gupta; O P Srivastava
Journal:  Mol Vis       Date:  2010-03-23       Impact factor: 2.367

9.  Zinc binding modulates the entire folding free energy surface of human Cu,Zn superoxide dismutase.

Authors:  Can Kayatekin; Jill A Zitzewitz; C Robert Matthews
Journal:  J Mol Biol       Date:  2008-09-26       Impact factor: 5.469

10.  Small heat-shock proteins regulate membrane lipid polymorphism.

Authors:  Nelly M Tsvetkova; Ibolya Horváth; Zsolt Török; Willem F Wolkers; Zsolt Balogi; Natalia Shigapova; Lois M Crowe; Fern Tablin; Elizabeth Vierling; John H Crowe; László Vigh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.